Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|April 23, 2026
CRAC channels as targets for immunotherapyKenneth Stauderman, Sudarshan Hebbar, Stefan Feske
Nephron|December 17, 2025
Bench to Bedside: Translating Discoveries to Clinical Care in Kidney DiseaseKatharine Epler, Dana Y Fuhrman, Sudarshan Hebbar, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2012
Bardoxolone methyl decreases megalin and activates nrf2 in the kidneyScott A Reisman, Glenn M Chertow, Sudarshan Hebbar, et al.
Critical Care (London, England)|August 16, 2020
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trialJoseph Miller, Charles Bruen, Michael Schnaus, et al.
American Journal of Nephrology|June 9, 2025
Inhibition of Calcium Release-Activated Calcium Channels to Treat Acute Kidney Injury: Design and Rationale of the KOURAGE Study a Randomized TrialLakhmir S Chawla, Patrick T Murray, Stuart L Goldstein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 7, 2004
Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis providerHarold J Manley, Cory G Garvin, Debra K Drayer, et al.
Critical Care (London, England)|April 9, 2022
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trialCharles Bruen, Mukhtar Al-Saadi, Edward A Michelson, et al.
Pageof 2